65 related articles for article (PubMed ID: 17471954)
1. [Aberrant mRNA splicing in human diseases].
Imaizumi K
Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2287-93. PubMed ID: 17471954
[No Abstract] [Full Text] [Related]
2. Pre-mRNA splicing and human disease.
Faustino NA; Cooper TA
Genes Dev; 2003 Feb; 17(4):419-37. PubMed ID: 12600935
[No Abstract] [Full Text] [Related]
3. HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1.
Irimura S; Kitamura K; Kato N; Saiki K; Takeuchi A; Gunadi ; Matsuo M; Nishio H; Lee MJ
Kobe J Med Sci; 2009 Mar; 54(5):E227-36. PubMed ID: 19628962
[TBL] [Abstract][Full Text] [Related]
4. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
Marquis J; Kämpfer SS; Angehrn L; Schümperli D
Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
[TBL] [Abstract][Full Text] [Related]
6. Nucleic Acid-Targeted Small Molecules have Therapeutic Potential in the Treatment of Spinal Muscular Atrophy: Small-molecule drugs that can selectively bind RNA and modulate pre-mRNA splicing have potential as a treatment strategy for human disease, including spinal muscular atrophy.
Am J Med Genet A; 2018 Aug; 176(8):1698-1699. PubMed ID: 30136439
[No Abstract] [Full Text] [Related]
7. RNA. Prescribing splicing.
Guigó R; Valcárcel J
Science; 2015 Jan; 347(6218):124-5. PubMed ID: 25574005
[TBL] [Abstract][Full Text] [Related]
8. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation and alternative splicing.
Estivill X
Nat Biotechnol; 2015 Apr; 33(4):357-9. PubMed ID: 25850059
[No Abstract] [Full Text] [Related]
10. A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches.
Eggermann T; Eggermann K; Elbracht M; Zerres K; Rudnik-Schöneborn S
Neuromuscul Disord; 2008 Feb; 18(2):146-9. PubMed ID: 18155522
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding proteins in human genetic disease.
Lukong KE; Chang KW; Khandjian EW; Richard S
Trends Genet; 2008 Aug; 24(8):416-25. PubMed ID: 18597886
[TBL] [Abstract][Full Text] [Related]
12. Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy.
Kernohan KD; Frésard L; Zappala Z; Hartley T; Smith KS; Wagner J; Xu H; McBride A; Bourque PR; Consortium CRC; Bennett SAL; Dyment DA; Boycott KM; Montgomery SB; Warman Chardon J
Hum Mutat; 2017 Jun; 38(6):611-614. PubMed ID: 28251733
[TBL] [Abstract][Full Text] [Related]
13. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.
Beattie CE; Carrel TL; McWhorter ML
J Child Neurol; 2007 Aug; 22(8):995-1003. PubMed ID: 17761655
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin nonsense mutations can generate alternative rescue transcripts in lymphocytes.
Nishiyama A; Takeshima Y; Zhang Z; Habara Y; Tran TH; Yagi M; Matsuo M
Ann Hum Genet; 2008 Nov; 72(Pt 6):717-24. PubMed ID: 18652600
[TBL] [Abstract][Full Text] [Related]
15. Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders.
Parkinson NJ; Baumer D; Rose-Morris A; Talbot K
Neuromuscul Disord; 2008 May; 18(5):394-7. PubMed ID: 18395445
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
[TBL] [Abstract][Full Text] [Related]
17. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
18. Animal models of spinal muscular atrophy.
Schmid A; DiDonato CJ
J Child Neurol; 2007 Aug; 22(8):1004-12. PubMed ID: 17761656
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
20. [Detection and diagnosis of hereditary monogenic neurologic diseases in Slovakia].
Jurasova A; Traubner P; Behulova R; Mezenska R; Lukacova M
Bratisl Lek Listy; 2000; 101(1):14-7. PubMed ID: 10824406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
